Search Page

1

Cite

Share

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.

Theivanthiran B, Evans KS, DeVito NC, Plebanek M, Sturdivant M, Wachsmuth LP, Salama AK, Kang Y, Hsu D, Balko JM, Johnson DB, Starr M, Nixon AB, Holtzhausen A, Hanks BA. Theivanthiran B, et al. Among authors: nixon ab. J Clin Invest. 2020 May 1;130(5):2570-2586. doi: 10.1172/JCI133055. J Clin Invest. 2020. PMID: 32017708 Free PMC article.

Cite

Share

2

Cite

Share

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study.

Lampert EJ, Zimmer A, Padget M, Cimino-Mathews A, Nair JR, Liu Y, Swisher EM, Hodge JW, Nixon AB, Nichols E, Bagheri MH, Levy E, Radke MR, Lipkowitz S, Annunziata CM, Taube JM, Steinberg SM, Lee JM. Lampert EJ, et al. Among authors: nixon ab. Clin Cancer Res. 2020 Aug 15;26(16):4268-4279. doi: 10.1158/1078-0432.CCR-20-0056. Epub 2020 May 12. Clin Cancer Res. 2020. PMID: 32398324 Free PMC article. Clinical Trial.

Cite

Share

3

Cite

Share

Bevacizumab biosimilars: scientific justification for extrapolation of indications.

Melosky B, Reardon DA, Nixon AB, Subramanian J, Bair AH, Jacobs I. Melosky B, et al. Among authors: nixon ab. Future Oncol. 2018 Oct;14(24):2507-2520. doi: 10.2217/fon-2018-0051. Epub 2018 Apr 25. Future Oncol. 2018. PMID: 29690784 Free article. Review.

Cite

Share

4

Cite

Share

Endoglin Targeting: Lessons Learned and Questions That Remain.

Liu Y, Paauwe M, Nixon AB, Hawinkels LJAC. Liu Y, et al. Among authors: nixon ab. Int J Mol Sci. 2020 Dec 25;22(1):147. doi: 10.3390/ijms22010147. Int J Mol Sci. 2020. PMID: 33375670 Free PMC article. Review.

Cite

Share

5

Cite

Share

Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.

Strickler JH, Rushing CN, Uronis HE, Morse MA, Niedzwiecki D, Blobe GC, Moyer AN, Bolch E, Webb R, Haley S, Hatch AJ, Altomare IP, Sherrill GB, Chang DZ, Wells JL, Hsu SD, Jia J, Zafar SY, Nixon AB, Hurwitz HI. Strickler JH, et al. Among authors: nixon ab. Oncologist. 2021 Jun;26(6):465-e917. doi: 10.1002/onco.13678. Epub 2021 Feb 9. Oncologist. 2021. PMID: 33469991 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Cabozantinib in ovarian clear cell cancers: UnMET expectations.

Secord AA, Previs RA, Nixon AB. Secord AA, et al. Among authors: nixon ab. Gynecol Oncol. 2018 Jul;150(1):1-2. doi: 10.1016/j.ygyno.2018.06.006. Gynecol Oncol. 2018. PMID: 29935857 No abstract available.

Cite

Share

7

Cite

Share

Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations.

Wetzel-Strong SE, Weinsheimer S, Nelson J, Pawlikowska L, Clark D, Starr MD, Liu Y, Kim H, Faughnan ME, Nixon AB, Marchuk DA. Wetzel-Strong SE, et al. Among authors: nixon ab. Orphanet J Rare Dis. 2021 Sep 3;16(1):372. doi: 10.1186/s13023-021-02009-7. Orphanet J Rare Dis. 2021. PMID: 34479577 Free PMC article.

Cite

Share

8

Cite

Share

Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.

Armstrong AJ, Nixon AB, Carmack A, Yang Q, Eisen T, Stadler WM, Jones RJ, Garcia JA, Vaishampayan UN, Picus J, Hawkins RE, Hainsworth JD, Kollmannsberger CK, Logan TF, Puzanov I, Pickering LM, Ryan CW, Protheroe A, George DJ, Halabi S. Armstrong AJ, et al. Among authors: nixon ab. Clin Cancer Res. 2021 Jun 15;27(12):3317-3328. doi: 10.1158/1078-0432.CCR-20-4504. Epub 2021 Feb 16. Clin Cancer Res. 2021. PMID: 33593885 Clinical Trial.

Cite

Share

9

Cite

Share

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.

Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB 3rd, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA. Guercio BJ, et al. Among authors: nixon ab. JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074. eCollection 2021 Feb. JNCI Cancer Spectr. 2020. PMID: 33426464 Free PMC article. Clinical Trial.

Cite

Share

10

Cite

Share

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?

Nixon AB, Schalper KA, Jacobs I, Potluri S, Wang IM, Fleener C. Nixon AB, et al. J Immunother Cancer. 2019 Nov 27;7(1):325. doi: 10.1186/s40425-019-0799-2. J Immunother Cancer. 2019. PMID: 31775882 Free PMC article. Review.

Cite

Share